American Heart Journal
Volume 144, Issue 6 , Pages 995-1002, December 2002

Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: Results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B)☆☆☆★★★

Ann Arbor, Mich, Cleveland, Ohio, Durham, NC, Auckland, New Zealand, and Haartmanikatu, Finland

From the aUniversity of Michigan Health System, Ann Arbor, Mich, bCleveland Clinic Foundation, Cleveland, Ohio, cDuke Clinical Research Institute, Durham, NC, dGreen Lane Hospital, Auckland, New Zealand, and eHelsinki University Central Hospital, Haartmanikatu 4, Finland

Received 11 January 2002; accepted 25 April 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported by Hoffman-LA Roche Ltd.

☆☆ Guest Editor for this manuscript was Richard C. Becker, MD, University of Massachusetts Medical Center, Worcester, Mass.

★ Reprint requests: Eric J. Topol, MD, FACC, Chairman, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, F 25, 9500 Euclid Ave, Cleveland, OH 44195.

★★ E-mail: topole@ccf.org

PII: S0002-8703(02)00223-5

doi:10.1067/mhj.2002.126118

American Heart Journal
Volume 144, Issue 6 , Pages 995-1002, December 2002

Article Tools

* Image Usage & Resolution